BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15034307)

  • 1. Oncogenic tyrosine kinases, DNA repair and survival: the role of Bcl-xL deamidation in transformation and genotoxic therapies.
    Alexander DR
    Cell Cycle; 2004 May; 3(5):584-7. PubMed ID: 15034307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation.
    Zhao R; Yang FT; Alexander DR
    Cancer Cell; 2004 Jan; 5(1):37-49. PubMed ID: 14749125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to antineoplastic therapy. The oncogenic tyrosine kinase-Bcl-x(L) axis.
    Weintraub SJ; Manson SR; Deverman BE
    Cancer Cell; 2004 Jan; 5(1):3-4. PubMed ID: 14749119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH.
    Zhao R; Oxley D; Smith TS; Follows GA; Green AR; Alexander DR
    PLoS Biol; 2007 Jan; 5(1):e1. PubMed ID: 17177603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-XL and Bcl-2 repress a common pathway of cell death.
    Chao DT; Linette GP; Boise LH; White LS; Thompson CB; Korsmeyer SJ
    J Exp Med; 1995 Sep; 182(3):821-8. PubMed ID: 7650488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 2-mediated uncoupling of T cell receptor alpha/beta from CD3 signaling.
    Haughn L; Leung B; Boise L; Veillette A; Thompson C; Julius M
    J Exp Med; 1998 Nov; 188(9):1575-86. PubMed ID: 9802969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage.
    Deverman BE; Cook BL; Manson SR; Niederhoff RA; Langer EM; Rosová I; Kulans LA; Fu X; Weinberg JS; Heinecke JW; Roth KA; Weintraub SJ
    Cell; 2002 Oct; 111(1):51-62. PubMed ID: 12372300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca(2+)-calmodulin antagonist chlorpromazine and poly(ADP-ribose) polymerase modulators 4-aminobenzamide and nicotinamide influence hepatic expression of BCL-XL and P53 and protect against acetaminophen-induced programmed and unprogrammed cell death in mice.
    Ray SD; Balasubramanian G; Bagchi D; Reddy CS
    Free Radic Biol Med; 2001 Aug; 31(3):277-91. PubMed ID: 11461765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL.
    Kutuk O; Temel SG; Tolunay S; Basaga H
    Eur J Cancer; 2010 Sep; 46(13):2494-505. PubMed ID: 20619636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Bcl-xL deamidation in human hepatocellular carcinomas.
    Takehara T; Takahashi H
    Cancer Res; 2003 Jun; 63(12):3054-7. PubMed ID: 12810626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deamidation of Bcl-X(L): a new twist in a genotoxic murder mystery.
    Johnstone RW
    Mol Cell; 2002 Oct; 10(4):695-7. PubMed ID: 12419210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.
    Jones RG; Parsons M; Bonnard M; Chan VS; Yeh WC; Woodgett JR; Ohashi PS
    J Exp Med; 2000 May; 191(10):1721-34. PubMed ID: 10811865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation.
    Marhäll A; Kazi JU; Rönnstrand L
    Sci Rep; 2017 Oct; 7(1):13734. PubMed ID: 29062038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibitor MG132-induced apoptosis via ER stress-mediated apoptotic pathway and its potentiation by protein tyrosine kinase p56lck in human Jurkat T cells.
    Park HS; Jun do Y; Han CR; Woo HJ; Kim YH
    Biochem Pharmacol; 2011 Nov; 82(9):1110-25. PubMed ID: 21819973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it.
    Rashmi R; Kumar S; Karunagaran D
    Carcinogenesis; 2004 Oct; 25(10):1867-77. PubMed ID: 15205359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase.
    Fan S; Ma YX; Wang JA; Yuan RQ; Meng Q; Cao Y; Laterra JJ; Goldberg ID; Rosen EM
    Oncogene; 2000 Apr; 19(18):2212-23. PubMed ID: 10822371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Bcl-3 through interaction with the Lck tyrosine kinase.
    Zhao Y; Ramakrishnan A; Kim KE; Rabson AB
    Biochem Biophys Res Commun; 2005 Sep; 335(3):865-73. PubMed ID: 16099425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated BCL-2 family proteins impact on repair of DNA double-strand breaks and are targets to overcome radioresistance in lung cancer.
    Wieczorek SA; Breitenbuecher F; Soni A; Paul-Konietzko K; Ziegler S; Sak A; Iliakis G; Schuler M
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1733-1744. PubMed ID: 28432456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.
    Anderson JS; Teutsch M; Dong Z; Wortis HH
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10966-71. PubMed ID: 8855292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 inhibition of T-cell proliferation is related to prolonged T-cell survival.
    Cheng N; Janumyan YM; Didion L; Van Hofwegen C; Yang E; Knudson CM
    Oncogene; 2004 May; 23(21):3770-80. PubMed ID: 15034548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.